Literature DB >> 26966868

ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.

Lihteh Wu1, Marcelo Zas, Maria H Berrocal, J Fernando Arevalo, Marta Figueroa, Francisco Rodriguez, Martin Serrano, Federico Graue, Arturo Alezzandrini, Roberto Gallego-Pinazo, José A Roca, Matias Iglicki, José Dalma-Weishauz, Igor Kozak, Alberto Collado, Josep Badal, Mauricio Maia, Guillermo Salcedo-Villanueva, Hugo Quiroz-Mercado, Jans Fromow-Guerra, David Lozano-Rechy, Marcos Avila, Jay Chhablani.   

Abstract

PURPOSE: To describe the natural history of eyes with symptomatic idiopathic vitreomacular traction (VMT).
METHODS: Retrospective multicenter study of 168 eyes with spectral-domain optical coherence tomography (SD-OCT) findings consistent with idiopathic VMT. All eyes were graded according to SD-OCT findings. Grade 1 was defined as incomplete cortical vitreous separation with foveal attachment. Grade 2 was defined as Grade 1 plus intraretinal cysts or clefts. Grade 3 was defined as Grade 2 plus a foveal detachment. All patients were followed for at least 6 months.
RESULTS: There were 168 patients (51 men) with a mean age of 68.8 ± 10.7 years. Patients were followed for a mean of 22.7 ± 20.1 months. The mean duration of symptoms before the initial presentation was 3.65 ± 5.42 months. At baseline, 72 eyes had Grade 1, 74 eyes had Grade 2, and 22 eyes had Grade 3 SD-OCT findings. Over the follow-up period, 36 eyes (21.4%) had spontaneous resolution of the VMT with normalization of the foveal anatomy. The mean time to resolution was 12.3 ± 12.6 months. An unfavorable anatomical outcome occurred in 7.7% (13 of 168) of the eyes, with 6 eyes developing a lamellar macular hole and 7 eyes developing a full-thickness macular hole. This occurred at a mean of 10.3 ± 10.7 months after the presentation. Subgroup analysis based on baseline SD-OCT grade showed that 4.1% (3 of 73) of Grade 1 eyes compared with 6.8% (5 of 74) of Grade 2 eyes, and 23.8% (5 of 21) of Grade 3 eyes developed a full-thickness macular hole or lamellar macular hole (P = 0.0109, chi-square test). In the remaining 119 eyes, at the last follow-up, 65 eyes had Grade 1, 42 eyes had Grade 2, and 12 eyes had Grade 3 VMT. On average, the best-corrected visual acuity improved from 0.40 ± 0.35 logarithm of the minimum angle of resolution (Snellen, 20/50) at baseline to 0.35 ± 0.36 logarithm of the minimum angle of resolution (Snellen, 20/45; P = 0.0372), and the mean central macular thickness improved from 350 ± 132 μm to 323 ± 121 μm.
CONCLUSION: Spontaneous resolution of VMT occurred in 21.4% (36 of 168) of eyes after a mean follow-up of 11.4 ± 12.6 months. An unfavorable anatomical outcome occurred in 7.7% (13 of 168) of eyes. The baseline SD-OCT grade may predict the progression to full-thickness macular hole.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26966868     DOI: 10.1097/IAE.0000000000001015

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Pneumatic release of focal vitreomacular traction.

Authors:  M G Claus; E Feron; M Veckeneer
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

2.  Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome

Authors:  Hüseyin Baran Özdemir; Şengül Özdek; Murat Hasanreisoğlu
Journal:  Turk J Ophthalmol       Date:  2019-09-03

3.  OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation.

Authors:  Ding-Ying Liao; Jorn-Hon Liu; Yu-Ping Zheng; Huei-Wen Shiu; Jian-Ming Wang; Hsiao-Ming Chao
Journal:  BMC Ophthalmol       Date:  2020-04-22       Impact factor: 2.209

4.  Factors Associated with the Clinical Course of Vitreomacular Traction.

Authors:  Petros Petrou; Evangelia Chalkiadaki; Marie-Helene Errera; Sidath Liyanage; Louisa Wickham; Evangelia Papakonstantinou; Aristotelis Karamaounas; Menelaos Kanakis; Ilias Georgalas; Stylianos Kandarakis; David Charteris
Journal:  J Ophthalmol       Date:  2020-12-21       Impact factor: 1.909

5.  ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.

Authors:  Ramin Tadayoni; Frank G Holz; Christophe Zech; Xin Liu; Claudio Spera; Peter Stalmans
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.